Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priti S Hegde

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Current Molecular Medicine|February 22, 2005
The transcriptome in blood: challenges and solutions for robust expression profilingHongtao Fan, Priti S Hegde
Immunity|January 16, 2020
Top 10 Challenges in Cancer ImmunotherapyPriti S Hegde, Daniel S Chen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2016
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint InhibitionPriti S Hegde, Vaios Karanikas, Stefan Evers
Drug Discovery Today|April 12, 2013
Interplay of transcriptomics and proteomicsPriti S Hegde, Ian R White, Christine Debouck
Current Opinion in Biotechnology|December 10, 2003
Interplay of transcriptomics and proteomicsPriti S Hegde, Ian R White, Christine Debouck
Seminars in Cancer Biology|December 13, 2017
Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeuticsPriti S Hegde, Jeffrey J Wallin, Christoph Mancao
Nature Medicine|September 16, 2022
Balancing speed, science and regulatory requirements in oncology drug developmentAlexandra Snyder, Dinesh De Alwis, Asthika Goonewardene, et al.
Molecular Cancer Therapeutics|May 22, 2007
Delineation of molecular mechanisms of sensitivity to lapatinib in breast cancer cell lines using global gene expression profilesPriti S Hegde, David Rusnak, Melissa Bertiaux, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
NF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragmentsJudit I Pulai, Hong Chen, Hee-Jeong Im, et al.
Plos One|February 3, 2021
C-reactive protein reduction post treatment is associated with improved survival in atezolizumab (anti-PD-L1) treated non-small cell lung cancer patientsNamrata S Patil, Wei Zou, Simonetta Mocci, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Current Molecular Medicine|February 22, 2005
The transcriptome in blood: challenges and solutions for robust expression profilingHongtao Fan, Priti S Hegde
Immunity|January 16, 2020
Top 10 Challenges in Cancer ImmunotherapyPriti S Hegde, Daniel S Chen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2016
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint InhibitionPriti S Hegde, Vaios Karanikas, Stefan Evers
Drug Discovery Today|April 12, 2013
Interplay of transcriptomics and proteomicsPriti S Hegde, Ian R White, Christine Debouck
Current Opinion in Biotechnology|December 10, 2003
Interplay of transcriptomics and proteomicsPriti S Hegde, Ian R White, Christine Debouck
Seminars in Cancer Biology|December 13, 2017
Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeuticsPriti S Hegde, Jeffrey J Wallin, Christoph Mancao
Nature Medicine|September 16, 2022
Balancing speed, science and regulatory requirements in oncology drug developmentAlexandra Snyder, Dinesh De Alwis, Asthika Goonewardene, et al.
Molecular Cancer Therapeutics|May 22, 2007
Delineation of molecular mechanisms of sensitivity to lapatinib in breast cancer cell lines using global gene expression profilesPriti S Hegde, David Rusnak, Melissa Bertiaux, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
NF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragmentsJudit I Pulai, Hong Chen, Hee-Jeong Im, et al.
Plos One|February 3, 2021
C-reactive protein reduction post treatment is associated with improved survival in atezolizumab (anti-PD-L1) treated non-small cell lung cancer patientsNamrata S Patil, Wei Zou, Simonetta Mocci, et al.
Pageof 6